End-stage kidney disease (ESKD) is a serious complication experience by many people with type 2 diabetes, and sometimes necessitate a kidney transplant. Researchers say delaying or preventing the onset of type 2 diabetes in people who have prediabetes can make a dramatic difference in their odds of developing ESKD. Read more
Researchers at the University of Michigan have developed an algorithm to help treat COVID-19 patients with diabetes. They hope this algorithm will help reduce the risk of complications like kidney failure and respiratory distress which are more likely to affect people with diabetes & the novel coronavirus. Read more
Hypoglycemia is a major risk for people with diabetes on insulin-containing regimens. These risks are even greater in those taking beta-blockers, as symptoms of low blood sugar can be masked by the drug. However, administering insulin with glucagon may help to reduce the risk, researchers say. Read more
High blood pressure and diabetes slow down memory and cognition, and the effects can be seen as early as middle age, say researchers who used subtle measurements to determine how the brain is affected in terms of memory and thinking speed at earlier ages. Read more
The coronavirus pandemic may have delayed diabetes diagnoses for many children with type 1, according to Italian researchers studying how diabetes diagnoses in 2020 have compared to historic data. Read more
The FDA has approved 2 additional doses of Eli Lilly’s Trulicity (dulaglutide) for treating type 2 diabetes. The approval of the new 3.0 mg and 4.5 mg doses of dulaglutide was based on clinical trial results showing benefits for A1C levels and weight loss. Read more
People with diabetes are at greater risk for severe complications of COVID-19, but researchers say people with well-controlled blood glucose levels, defined as 70-72mg/dL.(3.9-10 mmol/L), have better COVID-19 treatment outcomes. Read more
Researchers say they have identified insomnia as a risk factor for increased risk of developing type 2 diabetes (T2D). Their conclusion came as part of a study that identified 34 factors that could either increase or decrease the risk for type 2. Read more
Surgical procedures cause both physical and mental stress on patients, and higher stress level is associated with an increased risk of complications and death. Researchers examined the effectiveness of metformin use before surgeries to reduce the risk of complications in patients with type 2 diabetes. Read more
Multiple diabetes drugs are undergoing trials to see if they have a role to play in the fight against the novel coronavirus COVID-19. It’s already known that people with diabetes are at higher risk of serious complications from COVID-19; one reason may be that COVID-19 attacks the same bodily systems damaged by type 2 diabetes […]
The results from a major trial examining whether the diabetes drug ertugliflozin (brand name STEGLATRO), the VERTIS-CV trial, suggest that ertugliflozin is not superior to placebo in reducing major adverse cardiovascular events (MACE) but may reduce the rate of hospitalization for heart failure. Read more
Researchers at Massachusetts Institute of Technology (MIT) have developed a new synthetic film that could help manage diabetes. The material would be consumed as a liquid; the film has the ability to self-assemble in the intestine to block the absorption of glucose, and subsequently dissolve. Read more
Diets high in sugar content have been associated with numerous diseases and health conditions besides diabetes and obesity, such as cardiovascular disease, the leading cause of death in the U.S. Researchers have now found that high sugar consumption is linked to higher fat volume around the heart, which leads to coronary heart disease, coronary artery […]
Following a recent report that found Black Americans with diabetes have a limb amputation rate three times higher than non-Blacks, the American Diabetes Association (ADA) has created an initiative to prevent unnecessary amputations as part of a broader campaign to reduce racial disparities in diabetes care. Read more
Studies have found an association between exposure to high noise levels and the activation of stress hormones such as cortisol, which reduces pancreatic insulin secretion and decreases insulin sensitivity throughout the body, leading to increased risk of developing type 2 diabetes. This association is particularly dangerous for people with occupations that cause high levels of […]
Based on recent review of studies showing that the diabetes drug canagliflozin (Invokana) has many benefits for heart and kidney disease, and that the risk of amputation, while still increased with canagliflozin, is lower than previously described, the FDA has concluded that the boxed warning for increased amputation risk should be removed. It is still important […]
One of the major concerns amid the COVID-19 pandemic is the limited supply of mechanical ventilators. Since people with diabetes are at heightened risk of severe complications from COVID-19, which can sometimes require the use of intubation, a study looked at how to identify which patients are likely to need a ventilator. Read more
An intensive lifestyle intervention, designed to facilitate weight loss in adults with overweight or obesity and type 2 diabetes, lowers the incidence of obesity-related cancers by 16%. according to an analysis of findings from the Look AHEAD (Action for Health in Diabetes) trial. Read more
Getting an annual flu vaccine can lower risk of complications and even death in people with diabetes. People with diabetes are more susceptible to infections like influenza, which in turn puts them at higher risk for serious complications, including cardiovascular problems. Read more
A new study published in the New England Journal of Medicine found that an artificial pancreas system, using a continuous glucose monitoring (CGM) device and a separate insulin pump, was safe and beneficial in children with type 1 diabetes who were as young as six years of age. Read more